Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion-Reference-Cited by-同舟云学术

Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion

Published:2020-08 Issue: Volume:128 Page:84-91
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Vo N. Mai,Leung Melissa,van Rosendael Phillippe J.,Goedemans Laurien,van Wijngaarden Suzanne E.^ORCID,Prihadi Edgard A.,van der Bijl Pieter,Ajmone Marsan Nina,Delgado Victoria,Bax Jeroen J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease;Renda;J Am Coll Cardiol,2017

2. Dabigatran in patients with mechanical heart valves;Eikelboom;N Engl J Med,2014

3. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Europace,2016

4. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

5. Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry;Leung;Eur Heart J,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Electrical Cardioversion in Relation to Occurrence and Type of Functional Mitral Regurgitation in Patients with Atrial Fibrillation;Journal of Clinical Medicine;2022-04-07

2. Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study;Frontiers in Cardiovascular Medicine;2022-03-28